Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 1-aryl-1-hydroxy-1-substitute d-3-(4-substituted-1-piperazinyl)-2-propanones and their use in treatment of neurogenic bladder disorders

1-aryl-1-hydroxy-1-substitute d-3-(4-substituted-1-piperazinyl)-2-propanones and their use in treatment of neurogenic bladder disorders

US Patent 5001160 · Granted Mar 19, 1991

Estimated economic value: $32,272,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Nuclear reactor flow control devices and associated reactors, components, and me2024
Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of ves2023
Low-dose doxepin formulations and methods of making and using the same2021
Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of ves2021
Pharmaceutical formulations2021
Low-dose doxepin formulations and methods of making and using the same2020
Pharmaceutical formulations2019
Low-dose doxepin formulations and methods of making and using the same2018
Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of ves2017
Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicul2017
Low-dose doxepin formulations and methods of making and using the same2017
Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicul2016